Abstract
MYOTONIC dystrophy is a common dominant disorder (global incidence of 1:8,000) with variable onset and a protean nature of symptoms mainly involving progressive muscle wasting, myotonia and cataracts1. To define the molecular defect, we have cloned the essential region of chromosome 19ql3.3, including proximal and distal markers2–7 in a 700–kilobase contig formed by overlapping cosmids and yeast artificial chromosomes (YACs). The central part of the contig bridges an area of about 350 kilobases between two new flanking crossover borders4–5. This segment has been extensively characterized through the isolation of five YAC clones and the subsequent subcloning in cosmids from which a detailed EcoRl, HindIII, Mlul and Notl restriction map has been derived. Two genomic probes and two homologous complementary DNA probes were isolated using the cosmids. These probes are all situated within ∼10 kilobases of genomic DNA and detect an unstable genomic segment in myotonic dystrophy patients. The length variation in this segment shows similarities to the instability seen at the fragile X locus8. The physical map location and the genetic characteristics of the length polymorphism is compatible with a direct role in the pathogenesis of myotonic dystrophy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Harper, P. S. Myotonic Dystrophy 2nd edn (Saunders, London and Philadelphia, 1989).
Smeets, H., Hermens, R., Brunner, H. G., Ropers, H-H. & Wieringa, B. Genomics 9, 257–263 (1991).
Shutler, G. et al. Genomics 9, 500–504 (1991).
Shutler, G. et al. Genomics (in the press).
Jansen, G. et al. Genomics (in the press).
Johnson, K. et al. Am. J. hum. Genet. 46, 1073–1081 (1990).
Tsilfidis, C. et al. Am. J. hum. Genet. 49, 961–965 (1991).
Verkerk, A. J. M. H. et al. 65, 905–914 (1991).
De Jong, P. J. et al. Cytogen. Cell Genet. 51, 985 (1989).
Buxton, J. et al. Genomics (in the press).
Hermens, R., Coerwinkel, M., Brunner, H., Smeets, H. & Wieringa, B. Nucleic Acids Res. 19, 1726 (1991).
Tsilfidis, C., Shutler, G., Mahadevan, M. & Korneluk, R. G. Nucleic Acids Res. 19, 1157 (1991).
Korneluk, R. G. et al. Nucleic Acids Res. 19, 1157 (1991).
Burke, D., Carle, G. F. & Olsen, M. V. Science 236, 806–812 (1987).
Carrano, A. V. et al. Genomics 4, 129–136 (1989).
Branscomb, E. et al. Genomics 8, 351–366 (1991).
Lennon, G. G. et al. Hum. molec. Gen. (in the press).
Buxton, J. et al. Nature 355, 547–548 (1991).
Oberle, I. et al. Science 252, 1097–1102 (1991).
Yu, S. et al. Science 252, 1179–1181 (1991).
Shutler, G., Tsilfidis, C., Neville, C., Mahadevan, M. & Korneluk, R. G. Nucleic Acids Res. (in the press).
Brook, J. D. et al. J. med. Genet. 28, 84–88 (1991).
Harley, H. G. et al. Am. J. hum. Genet. 49, 68–75 (1991).
Griggs, R. C. et al. Neurology 39, 420–421 (1989).
La Spada, A. R., Wilson, E. M., Lubahn, D. B., Harding, A. E. & Fischbeck, K. H. Nature 352, 77–79 (1991).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Aslanidis, C., Jansen, G., Amemiya, C. et al. Cloning of the essential myotonic dystrophy region and mapping of the putative defect. Nature 355, 548–551 (1992). https://doi.org/10.1038/355548a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/355548a0
This article is cited by
-
Update on Therapy for Myotonic Dystrophy Type 1
Current Treatment Options in Neurology (2023)
-
DMPK hypermethylation in sperm cells of myotonic dystrophy type 1 patients
European Journal of Human Genetics (2022)
-
The DM-scope registry: a rare disease innovative framework bridging the gap between research and medical care
Orphanet Journal of Rare Diseases (2019)
-
Parental age effects, but no evidence for an intrauterine effect in the transmission of myotonic dystrophy type 1
European Journal of Human Genetics (2015)
-
Chronic muscle stimulation improves muscle function and reverts the abnormal surface EMG pattern in Myotonic Dystrophy: a pilot study
Journal of NeuroEngineering and Rehabilitation (2013)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.